Skip to main content

A health economic analysis of the introduction of a cell collection system (Cytosponge®) as a viable alternative to upper GI endoscopy in the COVID recovery

Published on 23 August 2022

From: Clinical Directorate

A project looking at the viability of a cell collection system alternative for COVID recovery



This project looked at the viability of Cytosponge as an alternative to endoscopy, in the continued quest for early diagnosis of oesophegal cancer, and to bring significant benefits to the health of the population.

If you require an alternative format, please contact